Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 18, No 2 (2025) Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis Abstract  similar documents
J. A. Agafonova
"... in 2022. The distribution of regimens by VEN groups was consistent with recommendations: 149 regimens (60 ..."
 
Vol 8, No 4 (2015) ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS Abstract  similar documents
A. N. Korobeynikova, S. V. Malchikova
"... and identify ways to optimize the consumption of medications. The objective of investigation is to hold ABC ..."
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract  similar documents
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
"... between various groups of drugs. Conclusion. The simultaneous use of the ABC/VEN and ATС/DDD analyzes ..."
 
Vol 7, No 1 (2014) ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT Abstract  similar documents
M. A. Shapovalova, L. R. Koretskaya
"... in Health Departmental Hospital station Astrahan 1 «Russian Railways», we carried out ABC and VEN analysis ..."
 
Vol 15, No 1 (2022) Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution Abstract  similar documents
O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov
"... for the reporting period of 2017–2018. We used the tools of ABC/VEN analysis and import substitution assessment ..."
 
Vol 17, No 4 (2024) The joint use of ABC/VEN analysis and the Beers criteria for optimizing expenditure of funds and rational prescribing of medications to elderly patients Abstract  similar documents
O. A. Makhmudova, G. F. Avkhadieva, O. G. Bagdanova, V. N. Khaziakhmetova
"... –2021 period. We conducted an integrated study combining ABC/VEN analysis and the Beers criteria ..."
 
Vol 9, No 4 (2016) PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION Abstract  similar documents
D. S. Kaskaeva, M. M. Petrova, O. V. Zimnitskaya
"... of combinations of drugs olmesartan/lercanidipine and zofenopril/lercanidipine. An ABC/VEN-analysis, сost ..."
 
Vol 9, No 2 (2016) EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL Abstract  similar documents
I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova
"... to the ABC/VEN analysis during the period from 2004 till 2014 we found positive dynamics of increase ..."
 
Vol 14, No 3 (2021) Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital Abstract  similar documents
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva
"... expenditure was carried out using ABC/VEN analysis. Results. The total expenditure on the procurement ..."
 
Vol 9, No 2 (2016) PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION Abstract  similar documents
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva
"... of International unlicensed name the necessary of which is in doubt. Conclusion. The ABC/ VEN analysis showed ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS Abstract  similar documents
E. E. Vidyakina, S. V. Malchikova
"... records of the patient, the analysis of cost of illness, ABC VEN — analysis. Results. The results of АВС ..."
 
Vol 16, No 2 (2023) Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 Abstract  similar documents
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova
"... ) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic ..."
 
Vol 12, No 3 (2019) Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings Abstract  similar documents
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev
"... an insignificant part (i.e., group C according to the ABC analysis). Notably, amikacin is prescribed more often ..."
 
Vol 10, No 3 (2017) ABC-analysis of pharmacotherapy in children hospitalized with bronchial asthma exacerbations Abstract  similar documents
O. V. Zhukova, S. V. Kononova
"... of pharmacotherapy was carried out in accordance with the ABC guidelines for an international non-proprietary name ..."
 
Vol 16, No 2 (2023) Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic Abstract  similar documents
Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham
"... funding in the Syrian Arab Republic (SAR), pharmacoeconomic study of antiretroviral therapy (ART) regimens ..."
 
Vol 14, No 2 (2021) Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting Abstract  similar documents
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov
"... regimens with centralized purchases and the cost of targeted drugs per hospitalization case were calculated ..."
 
Vol 11, No 2 (2018) Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations Abstract  similar documents
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov
"... The existing model of financial support of medical assistance for clinical-statistical groups (CSGs ..."
 
Vol 15, No 3 (2022) Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis Abstract  similar documents
А. V. Kukurika
"... drug-resistant tuberculosis (MDR/XDR-TB) chemotherapy regimens. Material and methods. An analysis ..."
 
Vol 16, No 2 (2023) Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure Abstract  similar documents
O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov
"... ” was calculated using DDD per 100 bed-days. ABC analysis was used to estimate the costs of drug groups in therapy ..."
 
Vol 14, No 2 (2021) Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region Abstract  similar documents
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin
"... drugs (bDMDs) within the constraints of diagnosis-related groups (DRGs) on the level of the Moscow ..."
 
Vol 16, No 2 (2023) Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance Abstract  similar documents
N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova
"... that 68.4% of patients in the group with bedaquiline-containing chemotherapy regimens reached the outcome ..."
 
Vol 6, No 4 (2013) Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk
"... » and «AICC + Eptacog alfa» schemes respectively. It is determined that the regimen «AICC + Eptacog alfa ..."
 
Vol 7, No 2 (2014) ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED Abstract  similar documents
M. G. Malaev
 
Vol 12, No 3 (2019) Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 Abstract  similar documents
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh
"... The article addresses the model of diagnosis-related groups (DRG) updated according to the new ..."
 
Vol 12, No 1 (2019) Evaluation of the clinical efficacy of anti-asthma pharmacotherapy in children using the software package based on the Fishburn method Abstract  similar documents
O. V. Zhukova, I. V. Nikiforova
"... Aim: to assess the clinical efficacy of pharmacotherapy regimens using a software package ..."
 
Vol 17, No 3 (2024) Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences Abstract  similar documents
E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov
"... Objective: to assess the demand for pharmacotherapy in risk groups on adverse cardiovascular (CV ..."
 
Vol 17, No 4 (2024) Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis Abstract  similar documents
J. A. Agafonova, V. V. Omelyanovskiy
"... into three groups: regimens with only oral administration, including combinations of multiple oral drugs ..."
 
Vol 10, No 2 (2017) CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES Abstract  similar documents
O. V. Zhukova, S. V. Kononova
"... -effectiveness” method) and socio-economic analysis of pharmaco-therapeutic regimens in a chronic disease ..."
 
Vol 12, No 3 (2019) Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support Abstract  similar documents
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov
"... Clinical / Economic Analysis and the common ABC / VEN analysis are currently used to estimate ..."
 
Vol 13, No 3 (2020) The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups Abstract  similar documents
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
"... Diagnosis-Related Groups (DRG) for the payment for biological therapy were created at the stage ..."
 
Vol 15, No 4 (2022) Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention Abstract  similar documents
V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova
"... of the therapy regimen including ticagrelor in combination with ASA on the target indicators of the State Health ..."
 
Vol 16, No 4 (2023) Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis Abstract  similar documents
A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva
"... Background. There are numerous diagnostic methods and therapy regimens for chronic tonsillitis (CT ..."
 
Vol 12, No 1 (2019) Individual cost accounting in the management of medical organizations Abstract  similar documents
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali
"... видам деятельности и ее модификации Time-driven ABC (TDABS), а также возможность их адаптации для ..."
 
Vol 16, No 4 (2023) Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma Abstract  similar documents
S. K. Zyryanov, K. V. Orlova
"... a regimen with BRAF/MEK inhibitors as the first line and prolgolimab as the second line in adult patients ..."
 
Vol 14, No 2 (2021) Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis Abstract  similar documents
N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova
"... chemotherapy regimens in the treatment of MDR/XDR-TB. Numerous studies have shown that, from a clinical point ..."
 
Vol 17, No 2 (2024) Mathematical modeling and analysis of export trends for certain pharmaceutical groups Abstract  similar documents
А. R. Shaikhislamova, N. А. Gasratova
"... Background. The analysis of the exports of medicines of the Russian Federation (RF) by group 30 ..."
 
Vol 18, No 2 (2025) Cosmetics as a product group of the Russian pharmaceutical market: analysis of competition and level of dominance Abstract  similar documents
N. I. Markov, L. S. Treshchetkina
"... published by DSM Group. The analysis employed the Linda index and the Herfindahl–Hirschman Index (HHI ..."
 
Vol 13, No 3 (2020) The review of the foreign experience on the financing of innovative medical technologies Abstract  similar documents
V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev
"... -related groups (DRG) does not contribute to the implementation of innovations in the medical practice ..."
 
Vol 18, No 1 (2025) Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia Abstract  similar documents
A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova
"... and marketing methods, including normalization of drug costs to weighted average prices (rub/mg), ABC analysis ..."
 
Vol 12, No 2 (2019) Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria Abstract  similar documents
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova
"... the alternative treatment regimens by 34.5-229.5 thousand rubles or 13.12-50.14%. According to the cost ..."
 
Vol 14, No 2 (2021) Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price Abstract  similar documents
D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov
"... study was performed to compare active platinum-containing chemotherapy regimens of the first line ..."
 
Vol 16, No 3 (2023) Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region Abstract  similar documents
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin
"... standard treatment regimens to quadritherapy, including in combination with a drug of the angiotensin ..."
 
Vol 16, No 4 (2023) Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C Abstract  similar documents
I. A. Narkevich, E. A. Tsitlionok
"... diagnosis of chronic hepatitis C. The first line therapy regimens were analyzed and compared ..."
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract  similar documents
L. S. Melnikova
 
Vol 10, No 3 (2017) The strategies of drug supply for patients with chronic hepatitis C Abstract  similar documents
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin
 
Vol 17, No 2 (2024) Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access Abstract  similar documents
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy
"... of diagnosis-related groups (DRGs) for cases of surgical medical care provided by laparoscopic access ..."
 
Vol 17, No 4 (2024) Pharmacoeconomic study of active psoriatic arthritis treatment Abstract  similar documents
A. V. Rudakova, Т. V. Korotaeva
"... evaluated regimens when using netakimab. For comparators, the costs to achieve an additional case ..."
 
Vol 10, No 4 (2017) THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE Abstract  similar documents
Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva
"... and statistical groups. ..."
 
Vol 11, No 2 (2018) Introduction of medical products into healthcare practice and costs reimbursement: European experience Abstract  similar documents
V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii
 
Vol 16, No 2 (2023) Methodological approach to the formation of the list of high-tech medical care types Abstract  similar documents
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy
"... groups (DRGs), on the one hand, significantly expanded the availability of HTMC methods ..."
 
1 - 50 of 197 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)